TLWM Financial’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.76M Buy
+9,279
New +$1.75M 0.29% 29
2026
Q1
Sell
-9,102
Closed -$1.67M 70
2025
Q4
$1.67M Sell
9,102
-157
-2% -$27.5K 0.31% 29
2025
Q3
$1.42M Buy
9,259
+545
+6% +$82.5K 0.26% 36
2025
Q2
$1.22M Buy
8,714
+84
+1% +$11.8K 0.23% 38
2025
Q1
$1.27M Buy
8,630
+289
+3% +$41.8K 0.25% 37
2024
Q4
$1.09M Buy
8,341
+359
+4% +$50.3K 0.22% 39
2024
Q3
$1.24M Sell
7,982
-207
-3% -$33.4K 0.25% 31
2024
Q2
$1.28M Buy
8,189
+137
+2% +$20.6K 0.27% 30
2024
Q1
$1.09M Buy
+8,052
New +$1.07M 0.24% 35

Other funds holding AZN

TLWM Financial's AZN Position: Q2 2026 in Review

TLWM Financial opened a new position in AstraZeneca (AZN) in Q2 2026: 9,279 shares worth $1.76M. The stake represents 0.29% of the portfolio and ranks #29 among its holdings. This is a return to the name: TLWM Financial previously reported a position in AZN as recently as Q4 2025.

TLWM Financial first reported a position in AZN in Q1 2024 and has held it in 9 quarters since. 233 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • TLWM Financial held 9,279 shares of AstraZeneca worth $1.76M as of Q2 2026.
  • AstraZeneca was a new TLWM Financial position in Q2 2026.
  • AstraZeneca made up 0.29% of TLWM Financial's portfolio in Q2 2026, its #29 holding.
  • TLWM Financial first reported a position in AstraZeneca in Q1 2024 and has held it in 9 quarters since.
  • 233 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on TLWM Financial's 13F filing for Q2 2026, filed 7 Jul 2026.